Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam.

Chen, Maylee

Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam. [electronic resource] - Drug metabolism and disposition: the biological fate of chemicals Dec 2006 - 2079-82 p. digital

Publication Type: Clinical Trial; Journal Article

0090-9556

10.1124/dmd.106.011742 doi


Administration, Oral
Adolescent
Adult
Cross-Over Studies
Cytochrome P-450 CYP3A Inhibitors
Enzyme Inhibitors--pharmacology
Female
Humans
Ketoconazole--pharmacology
Male
Midazolam--blood
Middle Aged